There Is No Cure For ALS, But Coya Therapeutics Might Have The Answer According To A New Clinical Study
SponsoredCoya Therapeutics: This BioPharma Company Has Some Big News To Share
SponsoredCoya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is A Major Moment For Drug Development
SponsoredCoya Therapeutics' COYA 302 Treating ALS Proves Effective In Proof-Of-Concept Academic Clinical Study
SponsoredCoya Therapeutics Recent News
Houston-Based Coya Therapeutics Partners With Multi-Billion Dollar Global Drug Company Dr. Reddy's Laboratories To License And Commercialize COYA 302
Sponsored
This Company Is Focused on Treg-Enhancing Therapies - Could This Be Medicine's Next Frontier?
Sponsored
Houston-Based Coya Therapeutics To Present Results From ALS Clinical Study Data For Its Investigational Biologic Combination at the 2023 MDA Clinical & Scientific Conference in Dallas
Sponsored
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Sponsored